NXU yields 81.63% · PFE yields 6.13%● Live data
📍 NXU pulled ahead of the other in Year 1
Combined, NXU + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXU + PFE for your $10,000?
Nxu, Inc, a technology company, engages in the developing of next-generation electric vehicle charging, battery, and vehicle technologies for mobility customers in the United States. The company offers NxuOne, a charging technology provides repeatable, consistent power delivery, designed to meet the needs of electric vehicles; Nxu battery cell and packs designed to leverage an in-house developed NMC-811 chemistry, combined with proprietary mechanical construction to improve thermal management and reduce electrical resistance. It also provides Nxu EV platform, a modular vehicle system or electric skateboard, which provides technology, software, and mobility technology for vehicle by third parties; and Nxu pickup truck, a flagship vehicle and 100% electric full-sized truck. Nxu, Inc. was incorporated in 2016 and is headquartered in Mesa, Arizona.
Full NXU Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.